A spike in COVID-19 cases across the U.S. has led to a national shortage of convalescent plasma.
That's blood plasma taken from people who have recovered from COVID-19.
A spike in COVID-19 cases across the U.S. has led to a national shortage of convalescent plasma.
That's blood plasma taken from people who have recovered from COVID-19.